• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 3
  3. Author

Online ISSN: 2515-8260

Volume9, Issue3

To compare various biomarkers in head and neck squamous cell carcinoma pre and post treatment

    Dr. SumitDokwal,Dr. Rajesh Kumar,Dr. Ajit Singh, Dr. KiranDahiya, Dr. Rajeev Atri,Dr. RakeshDhankhar

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 3, Pages 2979-2990

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Introduction: In India, head and neck cancer is the commonest cancer in men and in both
sexes.In most cases, due to extensive loco-regional involvement, poor general condition of the
patient, or co-morbid conditions, curative treatment is not possible. Aims & Objectives: To
know serum Magnesium levels in patients of head and neck squamous cell carcinoma before
and after treatment. Data & Methodology: This study was conducted in the Department of
Biochemistry in collaboration with Department of Radiotherapy, Pt BD Sharma Post
Graduate Institute of Medical Sciences, Rohtak, India. For the completion of the study, 30
newly diagnosed patients with HNSCC, and 30 age and sex matched healthy individuals were
taken. Chi-square and t-test were applied to know the association and comparison between
case and control group respectively. Results: The subjects were categorized into three groups
such asgroup A- Pretreatment cases, group B- Post-treatment cases and group C- Controls.
Plasma glucose in group A was 84.73 ± 2.97 (57-115)mg/dL. Plasma glucose in group B was
103.46±5.15 (61-171) mg/dL whereas group C plasma glucose was 84.73±2.97 (57-115)
mg/dL. p value between group A and group B was 0.001. It was found significant difference
between cases before and after treatment in glucose levels. The levels in cases before treatment
were found significantly different from controls regarding ALT, Albumin, total protein and
TBIL with p values 0.015, 0.020 respectivelyConclusions: It was found highly significant
difference between case and control groups especially for LDL, Protein and Calcium wise
classification respectively.
Keywords:
    EDTA vacutainer LDL-C HDL-C chronic disease
  • PDF (485 K)
  • XML
(2022). To compare various biomarkers in head and neck squamous cell carcinoma pre and post treatment. European Journal of Molecular & Clinical Medicine, 9(3), 2979-2990.
Dr. SumitDokwal,Dr. Rajesh Kumar,Dr. Ajit Singh, Dr. KiranDahiya, Dr. Rajeev Atri,Dr. RakeshDhankhar. "To compare various biomarkers in head and neck squamous cell carcinoma pre and post treatment". European Journal of Molecular & Clinical Medicine, 9, 3, 2022, 2979-2990.
(2022). 'To compare various biomarkers in head and neck squamous cell carcinoma pre and post treatment', European Journal of Molecular & Clinical Medicine, 9(3), pp. 2979-2990.
To compare various biomarkers in head and neck squamous cell carcinoma pre and post treatment. European Journal of Molecular & Clinical Medicine, 2022; 9(3): 2979-2990.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 40
  • PDF Download: 91
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus